Recent Advances in the Understanding of Sepsis-Induced Alterations in the Neuroendocrine System

被引:16
|
作者
Wahab, Fazal [1 ,2 ]
Atika, Bibi [2 ]
Oliveira-Pelegrin, Gabriela Ravanelli [1 ]
Alves Rocha, Maria Jose [1 ]
机构
[1] Univ Sao Paulo, Dept Morphol Physiol & Basic Pathol, FORP, BR-14040904 Sao Paulo, Brazil
[2] Khyber Med Univ, Inst Basic Med Sci, Dept Physiol, Peshawar, Pakistan
基金
巴西圣保罗研究基金会;
关键词
Cytokines; hormonal therapy; hypothalamus; immune system; neuroendocrine system; neuroendocrinopathy; pituitary; sepsis; PITUITARY-ADRENAL AXIS; THYROTROPIN-RELEASING-HORMONE; INNATE IMMUNE-RESPONSES; NITRIC-OXIDE SYNTHASE; GENE-EXPRESSION; INDUCED SUPPRESSION; VASOPRESSIN SECRETION; MAGNOCELLULAR NEURONS; NONTHYROIDAL ILLNESS; CECAL LIGATION;
D O I
10.2174/1871530313666131211120723
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is a fatal systemic inflammatory disease. It is caused by an immune system inflammatory response to the entry of microorganisms or their products into the blood circulatory system. The pathophysiological mechanisms of sepsis are still poorly understood. The presence of microorganisms in the systemic circulation causes activation of the immune system, which in turn leads to a robust release of inflammatory cytokines. These inflammatory cytokines result in alterations across all important physiological systems, including the neuroendocrine system. Neuroendocrine responses differ between the acute and the late phase of sepsis. In the acute phase there are robust alterations in the secretion of neuroendocrine hormones in response to body demand. In the late phase, the plasma concentrations of some hormones remain low, despite heavy systemic demand, whereas several others increase despite of diminished needs. In this review, we give a brief overview on sepsis-induced major alterations in neuroendocrine secretions, and summarize current knowledge about mechanisms and targets for their treatment.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 50 条
  • [41] Sepsis-Induced Tissue Hypoperfusion
    Jones, Alan E.
    Puskarich, Michael A.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2011, 23 (01) : 115 - +
  • [42] Sepsis-induced myocardial dysfunction
    Sharma, A. C.
    SHOCK, 2006, 25 : 14 - 15
  • [43] Pathophysiology of sepsis-induced cardiomyopathy
    Steven M. Hollenberg
    Mervyn Singer
    Nature Reviews Cardiology, 2021, 18 : 424 - 434
  • [44] A review of sepsis-induced cardiomyopathy
    Sato R.
    Nasu M.
    Journal of Intensive Care, 3 (1)
  • [45] Pathophysiology of sepsis-induced cardiomyopathy
    Hollenberg, Steven M.
    Singer, Mervyn
    NATURE REVIEWS CARDIOLOGY, 2021, 18 (06) : 424 - 434
  • [46] Sepsis-induced myocardial dysfunction
    Walley, Keith R.
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (04) : 292 - 299
  • [47] Sepsis-induced brain dysfunction
    Adam, Nicolas
    Kandelman, Stanislas
    Mantz, Jean
    Chretien, Fabrice
    Sharshar, Tarek
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (02) : 211 - 221
  • [48] INSTANTANEOUS SEPSIS-INDUCED CARDIOMYOPATHY
    Haq, Haroon
    McGee, William
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 681 - 681
  • [49] Sepsis-Induced Tissue Hypoperfusion
    Jones, Alan E.
    Puskarich, Michael A.
    CRITICAL CARE CLINICS, 2009, 25 (04) : 769 - +
  • [50] Sepsis-induced myocardial dysfunction
    Sharma, Avadhesh C.
    SHOCK, 2007, 28 (03): : 265 - 269